Yunpeng Pharmaceutical Group Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Yunpeng Pharmaceutical Group Co.,Ltd.

26 YRS

Shanxi, China

CNY 200 Million

42624 m²

100-500 people

Main Products: Mexiletine Hydrochloride / Sulfonium, (3-Amino-3-Carboxypropyl)Dimethyl-, Chloride / Indometacin / S-Carboxymethyl-L-Cysteine / Aluminium Hydroxide / Ranitidine Hydrochloride / Albuterol Sulfate / Magnesium Trisilicate / Norfloxacin / Cimetidine / Calcium D-Pantothenate / Pyridoxine / Fusidic Acid / Acetaminophen / Phenolphthalein / Metronidazole / Nifedipine / Hydrochlorothiazide / Kasugamycin / Nystatin / Riboflavin (B2) / Gamma-Oryzanol / Tamoxifen Citrate / Cystamine Dihydrochloride / Chloro Hydrozine

Shanxi, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

ABOUT US

Yunpeng Pharmaceutical Group is a comprehensive high-tech enterprise integrating drug R & D, production, sales and logistics. It has 200 approval numbers, 9 subsidiaries and 1 branch, with a total asset value of 1.2 billion yuan. The group has a modern production base and R & D pilot base with chemical drugs, traditional Chinese medicine and API as the core; One traditional Chinese medicine extraction production line, four R & D pilot production lines, ten oral preparation production lines, eleven chemical API production lines and injection molding production lines have passed the new version of GMP certification. The EU workshop for APIs and the EU workshop for oral preparations will be completed soon. The Group invested 100 million yuan to establish Beijing Yunpeng Pengcheng Pharmaceutical Research Institute in 2018, invested 8-10% of the profit in R & D every year, and cooperated with 6 companies such as fangtaida Co., Ltd., a famous international pharmaceutical giant. It has won the titles of "high-tech enterprise" and "high-tech innovation enterprise". The group has successively established business cooperation relations with India, Japan, the United Kingdom, South Korea and other countries, and its sales network is all over the world. At present, norfloxacin, indomethacin and mexiletine hydrochloride have been registered in India, while indomethacin has been registered in Russia, Mexico, Egypt, South Korea and other places. In Japan, mexiletine hydrochloride and vitamin U have also been reviewed by jdmf. The group has introduced advanced management concepts to build an industrialized, information-based and intelligent enterprise. At the same time, it has obtained environmental assessment certificate, safety assessment certificate, fire protection certificate, sewage discharge certificate and water intake certificate, and its strength has been comprehensively improved; And won the title of "management benchmarking enterprise in Shanxi Province" and "qualified unit for pilot work of enterprise environmental supervisor". In the future, Yunpeng people will continue to uphold the corporate mission of "contributing to the society and delivering health to the people", devote themselves to the cause of human health, and spread health and take care of life with more, newer and better health products!

Basic Information